|
SU1731811A1
|
|
Strain b/60/32/p of influenza virus b, used for preparation of living intranasal vaccine for adult and children
|
|
RU1769886C
|
|
Method for treatment of hypertonic disease
|
|
RU1787434C
|
|
Stereotactic apparatus for rodents
|
|
SU1660701A1
|
|
Method for treating epilepsy cases
|
|
SU1671266A1
|
|
Method for tremor arrest
|
|
SU1498454A1
|
|
Method of predicting outcome of treatment of purulent meningitis of children
|
|
SU1359300A1
|
|
Method of determining antiinfection activity of biologically active compounds
|
|
SU1264576A1
|
|
Method of producing live vaccine against flu
|
|
SU1219644A1
|
|
Influenza virus a/f/59/1 strain used for producing inactivated influenza virus vaccine
|
|
SU1377037A1
|
|
Method of assessing functional state of manъs central nervous system
|
|
SU1055504A1
|
|
Apparatus for creating physical model of intracerebral space
|
|
SU1007228A1
|
|
Method of purifying ceruloplasmin
|
|
SU774549A1
|
|
Method of thermal influence on biologic tissues
|
|
US4211764A
|
|
Gastric secretion stimulation with 2-amino-5-(2-aminoethyl)-1,3,4-thiadiozole
|
|
SU637408A1
|
|
Method of obtaining 1,2-dimethyl-7-nitro-benzimidazole
|
|
CA1072964A
|
|
P, p"-bis-quaternary ammonium salts of p-terphenyl and method of preparing same
|
|
SU596577A1
|
|
N-methyl-n'-4-(5-amino-1,2,4-triazolyl-3)-butyl/-thiourea showing antihistaminic activity and method of obtaining same
|
|
SU628921A1
|
|
Composition exhibiting anti-curare action, for use in experiment
|
|
SU685289A1
|
|
Tercuronium miorelaxant
|
|
SU757520A1
|
|
Aliphatic asymmetric bis-ammonia derivatives exhibiting ganglia-blocking activity
|
